Legend Biotech (LEGN) Short Interest Ratio & Short Volume

Short interest is the volume of Legend Biotech shares that have been sold short but have not yet been covered or closed out. As of February 15th, traders have sold 13,340,000 shares of LEGN short. 7.31% of Legend Biotech's shares are currently sold short. Learn More on Legend Biotech's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LEGN shares currently have a short interest ratio of 10.0. Learn More on Legend Biotech's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Legend Biotech: OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC , Group One Trading LLC, D. E. Shaw & Co. Inc., Caption Management LLC, Citadel Advisors LLC, Jane Street Group LLC, Tudor Investment Corp ET AL, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.31% of Legend Biotech's floating shares are currently sold short.

Legend Biotech saw a increase in short interest in February. As of February 15th, there was short interest totaling 13,340,000 shares, an increase of 5.6% from the previous total of 12,630,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

7.31% of Legend Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Legend Biotech: Teva Pharmaceutical Industries Limited (2.37%), Genmab A/S (0.26%), Summit Therapeutics Inc. (24.86%), Intra-Cellular Therapies, Inc. (2.23%), Viatris Inc. (2.36%), Moderna, Inc. (12.38%), Dr. Reddy's Laboratories Limited (2.26%), Vaxcyte, Inc. (11.04%), Sarepta Therapeutics, Inc. (5.58%), Ascendis Pharma A/S (9.97%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($25.81 billion), iShares 20+ Year Treasury Bond ETF ($10.38 billion), MicroStrategy Incorporated ($7.74 billion), AppLovin Co. ($6.32 billion), Apollo Global Management, Inc. ($5.97 billion), Super Micro Computer, Inc. ($4.89 billion), Charter Communications, Inc. ($4.52 billion), Capital One Financial Co. ($3.94 billion), Schlumberger Limited ($3.19 billion), and Reddit, Inc. ($3.01 billion). View all of the most shorted stocks.

Short selling LEGN is an investing strategy that aims to generate trading profit from Legend Biotech as its price is falling. LEGN shares are trading down $2.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Legend Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEGN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEGN, twice per month. The most recent reporting period available is February, 15 2025.